GSA Capital Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Buy |
+4,971
| New | +$976K | 0.07% | 471 |
|
|
2025
Q3 | – | Sell |
-6,139
| Closed | -$1.1M | – | 1738 |
|
|
2025
Q2 | $1.1M | Buy |
+6,139
| New | +$1.07M | 0.08% | 393 |
|
|
2022
Q4 | – | Sell |
-1,891
| Closed | -$232K | – | 1558 |
|
|
2022
Q3 | $232K | Buy |
+1,891
| New | +$249K | 0.03% | 1115 |
|
|
2021
Q4 | – | Sell |
-10,002
| Closed | -$1.45M | – | 1479 |
|
|
2021
Q3 | $1.45M | Buy |
+10,002
| New | +$1.46M | 0.15% | 138 |
|
|
2021
Q1 | – | Sell |
-4,742
| Closed | -$565K | – | 1188 |
|
|
2020
Q4 | $565K | Buy |
+4,742
| New | +$578K | 0.09% | 354 |
|
|
2020
Q2 | – | Sell |
-4,465
| Closed | -$359K | – | 711 |
|
|
2020
Q1 | $359K | Buy |
+4,465
| New | +$462K | 0.09% | 365 |
|
|
2018
Q4 | – | Sell |
-41,495
| Closed | -$4.48M | – | 1417 |
|
|
2018
Q3 | $4.48M | Buy |
41,495
+34,626
| +504% | +$3.8M | 0.25% | 22 |
|
|
2018
Q2 | $755K | Sell |
6,869
-14,725
| -68% | -$1.53M | 0.04% | 916 |
|
|
2018
Q1 | $2.17M | Buy |
21,594
+10,023
| +87% | +$1.03M | 0.11% | 245 |
|
|
2017
Q4 | $1.14M | Sell |
11,571
-19,985
| -63% | -$1.89M | 0.07% | 522 |
|
|
2017
Q3 | $2.96M | Buy |
31,556
+29,418
| +1,376% | +$3.12M | 0.2% | 52 |
|
|
2017
Q2 | $238K | Sell |
2,138
-4,392
| -67% | -$464K | 0.02% | 1431 |
|
|
2017
Q1 | $641K | Buy |
+6,530
| New | +$622K | 0.03% | 943 |
|
|
2016
Q3 | – | Sell |
-10,978
| Closed | -$894K | – | 1804 |
|
|
2016
Q2 | $894K | Buy |
+10,978
| New | +$836K | 0.05% | 706 |
|
|
2015
Q4 | – | Sell |
-10,223
| Closed | -$628K | – | 1842 |
|
|
2015
Q3 | $628K | Sell |
10,223
-9,202
| -47% | -$643K | 0.03% | 983 |
|
|
2015
Q2 | $1.41M | Buy |
19,425
+4,419
| +29% | +$326K | 0.05% | 623 |
|
|
2015
Q1 | $1.15M | Buy |
+15,006
| New | +$1.07M | 0.05% | 745 |
|
|
2014
Q4 | – | Sell |
-29,831
| Closed | -$1.81M | – | 1738 |
|
|
2014
Q3 | $1.81M | Sell |
29,831
-41,759
| -58% | -$2.57M | 0.1% | 225 |
|
|
2014
Q2 | $4.2M | Buy |
71,590
+55,495
| +345% | +$3.25M | 0.19% | 83 |
|
|
2014
Q1 | $932K | Sell |
16,095
-45,431
| -74% | -$2.43M | 0.07% | 370 |
|
|
2013
Q4 | $3.29M | Buy |
+61,526
| New | +$3.65M | 0.26% | 39 |
|
|
2013
Q3 | – | Sell |
-7,529
| Closed | -$456K | – | 1576 |
|
|
2013
Q2 | $456K | Buy |
+7,529
| New | +$449K | 0.05% | 603 |
|
Other funds holding DGX
EIG
GSA Capital Partners's DGX Position: Q2 2026 in Review
GSA Capital Partners opened a new position in Quest Diagnostics (DGX) in Q2 2026: 4,971 shares worth $1.05M. The stake represents 0.07% of the portfolio and ranks #471 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in DGX as recently as Q2 2025.
GSA Capital Partners first reported a position in DGX in Q2 2013 and has held it in 22 quarters since. The position peaked at $4.48M in Q3 2018. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- GSA Capital Partners held 4,971 shares of Quest Diagnostics worth $1.05M as of Q2 2026.
- Quest Diagnostics was a new GSA Capital Partners position in Q2 2026.
- Quest Diagnostics made up 0.07% of GSA Capital Partners's portfolio in Q2 2026, its #471 holding.
- GSA Capital Partners first reported a position in Quest Diagnostics in Q2 2013 and has held it in 22 quarters since.
- GSA Capital Partners's Quest Diagnostics position peaked at $4.48M in Q3 2018.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.